These findings were confirmed in the azoxymethane (AOM) and DSS mouse model, in which administration of anti-CTLA4 antibody was less effective in reducing tumor numbers in the colon of H. pylori-infected compared to non-infected mice. The gene discussed is CTLA4; the disease is neoplasm.